GHO Capital and Partners Group Invest in Sterling Pharma Solutions
May 25, 2023
GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.
- Buyers
- GHO Capital Partners LLP, Partners Group, AlpInvest Partners (funds managed by AlpInvest), Pantheon
- Targets
- Sterling Pharma Solutions
- Industry
- Pharmaceuticals
- Location
- United Kingdom
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
GHO Capital Acquires Majority Stake in Sterling Pharma Solutions
February 28, 2019
Pharmaceuticals
GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.
-
GHO Capital Invests in Sanner Group
October 26, 2021
Medical Devices
GHO Capital Partners LLP has made a majority investment in Sanner Group (Sanner GmbH), a Germany‑based manufacturer of active packaging solutions and components for pharmaceutical, diagnostic, nutraceutical and medtech customers. GHO will partner with the Sanner family and existing management to accelerate global expansion—including capacity expansion in Germany and China and entry into the U.S.—and to invest in product development, sustainability and sales growth.
-
GHO Capital Leads Consortium to Acquire Majority Stake in Envision Pharma Group from Ardian
November 5, 2020
Healthcare Services
GHO Capital Partners, leading a consortium that includes Mubadala Investment Company, HarbourVest Partners and Northwestern Mutual, together with Envision management and employees, has acquired a majority stake in Envision Pharma Group as Ardian exits its investment. The transaction will support Envision's continued growth, wider rollout of its iEnvision medical affairs platform and strategic acquisitions to expand its medical affairs, communications and technology capabilities.
-
Sterling Pharma Solutions Acquires ADC Biotechnology
April 7, 2021
Biotechnology
Sterling Pharma Solutions, a GHO Capital portfolio CDMO, has acquired ADC Biotechnology (ADC Bio), a Deeside-based bioconjugation and ADC development services business. The deal adds ADC capabilities and a Deeside facility to Sterling’s international network and includes multi-million pound investment to grow bioconjugation, analytical and cGMP ADC manufacturing capabilities.
-
Sterling Pharma Solutions Acquires Alcami's Germantown (WI) API Facility
October 1, 2020
Pharmaceuticals
Sterling Pharma Solutions, a portfolio company of GHO Capital Partners, has acquired Alcami’s Germantown, Wisconsin API development and manufacturing facility. The facility expands Sterling’s US footprint and adds cGMP capacity for complex and hazardous API projects, including plant-scale hydrogenation and cryogenic reactions.
-
GHO Capital Partners Acquires Majority Stake in Sapio Sciences
December 1, 2022
Cloud & SaaS
London-based healthcare investor GHO Capital Partners has acquired a majority stake in Sapio Sciences, a US-based lab informatics platform providing LIMS, ELN and scientific data management solutions. GHO will support Sapio's international expansion (especially into Europe), operational improvements and growth through M&A to scale the company's SaaS offering for biopharma, CROs and diagnostic labs.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.